X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15) 15
index medicus (14) 14
female (11) 11
oncology (11) 11
male (9) 9
middle aged (9) 9
aged (7) 7
care and treatment (5) 5
lung neoplasms - drug therapy (5) 5
lung neoplasms - pathology (5) 5
adult (4) 4
carcinoma, non-small-cell lung - drug therapy (4) 4
carcinoma, non-small-cell lung - pathology (4) 4
cell lung-cancer (4) 4
patients (4) 4
safety (4) 4
solid tumors (4) 4
analysis (3) 3
antibodies, monoclonal - adverse effects (3) 3
antibodies, monoclonal, humanized - administration & dosage (3) 3
biopsy (3) 3
breast cancer (3) 3
chemotherapy (3) 3
genetic aspects (3) 3
hematology (3) 3
lung cancer (3) 3
lung cancer, non-small cell (3) 3
lung neoplasms - mortality (3) 3
medicine, general & internal (3) 3
metastasis (3) 3
multicenter (3) 3
mutation (3) 3
non-small cell lung cancer (3) 3
research (3) 3
respiratory system (3) 3
therapy (3) 3
tumors (3) 3
acquired-resistance (2) 2
acute kidney injury - etiology (2) 2
aged, 80 and over (2) 2
animals (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antineoplastic agents - therapeutic use (2) 2
apoptosis (2) 2
bevacizumab (2) 2
cancer (2) 2
cancer therapies (2) 2
carboplatin (2) 2
carboplatin - administration & dosage (2) 2
development and progression (2) 2
diagnosis, differential (2) 2
disease-free survival (2) 2
docetaxel (2) 2
drug administration schedule (2) 2
efficacy (2) 2
expression (2) 2
hematology, oncology and palliative medicine (2) 2
infusion (2) 2
lung neoplasms - blood supply (2) 2
medicine & public health (2) 2
medicine, research & experimental (2) 2
mice (2) 2
multiple myeloma - diagnosis (2) 2
neoplasm staging (2) 2
neoplasms - blood (2) 2
neutropenia (2) 2
open-label (2) 2
paclitaxel (2) 2
paclitaxel - administration & dosage (2) 2
pharmacology (2) 2
product development (2) 2
protein kinase inhibitors - therapeutic use (2) 2
research article (2) 2
survival analysis (2) 2
trial (2) 2
usage (2) 2
vegf (2) 2
30-min infusion (1) 1
abridged index medicus (1) 1
acquired immunodeficiency syndrome - complications (1) 1
acquired resistance (1) 1
adenocarcinoma (1) 1
administration, oral (1) 1
advanced nonsquamous non-small-cell lung cancer (1) 1
advanced solid tumors (1) 1
aids (1) 1
albumins - administration & dosage (1) 1
albumins - adverse effects (1) 1
alleles (1) 1
american women (1) 1
anemia (1) 1
anemia - etiology (1) 1
anemia, hemolytic, autoimmune - complications (1) 1
anemia, hemolytic, autoimmune - drug therapy (1) 1
angiogenesis (1) 1
angiogenesis inducing agents - blood (1) 1
angiogenesis inhibitor (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
anreicherung (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, p. e0140712
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 2/2018, Volume 167, Issue 3, pp. 671 - 686
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e23072 - e23072
Journal Article
British Journal of Haematology, ISSN 0007-1048, 04/2017, Volume 177, Issue 2, pp. 243 - 253
Journal Article
by Paz-Ares, Luis and Dvorkin, Mikhail and Chen, Chengshui and Chen, Yen-Hsun and Chen, Yuan and Chen, Yuanbin and Chen, Zhendong and Reinmuth, Niels and Hotta, Katsuyuki and Trukhin, Dmytro and Statsenko, Galina and Hochmair, Maximilian J and Özgüroğlu, Mustafa and Ji, Jun Ho and Voitko, Nataliia and Voitko, Oleksandr and Poltoratskiy, Artem and Ponce, Santiago and Verderame, Francesco and Havel, Libor and Bondarenko, Igor and Kazarnowicz, Andrzej and Losonczy, György and Conev, Nikolay V and Armstrong, Jon and Byrne, Natalie and Shire, Norah and Jiang, Haiyi and Goldman, Jonathan W and Batagelj, Emilio and Casarini, Ignacio and Pastor, Anea Viviana and Sena, Susana Noemi and Zarba, Juan Jose and Burghuber, Otto and Hartl, Sylvia and Lamprecht, Bernd and Studnicka, Michael and Alberto Schlittler, Luis and Augusto Martinelli de Oliveira, Fabricio and Calabrich, Aknar and Colagiovanni Girotto, Gustavo and Dos Reis, Peo and Fausto Nino Gorini, Carlos and Rafael Martins De Marchi, Peo and Serodio da Rocha Baldotto, Clarissa and Sette, Claudia and Zukin, Mauro and Dudov, Assen and Ilieva, Rumyana and Koynov, Krassimir and Krasteva, Rositsa and Tonev, Ivan and Valev, Spartak and Venkova, Violetka and Bi, Minghong and Fang, Jian and Feng, Jifeng and Han, Zhigang and Hu, Jie and Hu, Yi and Li, Wei and Li, Chien-Te and Liang, Zongan and Lin, Zhong and Ma, Shenglin and Ma, Rui and Nan, Kejun and Shu, Yongqian and Wang, Chin-Chou and Wang, Kai and Wang, Mengzhao and Wu, Gang and Wu, Shang-Yin and Yang, Nong and Yang, Zhixiong and Zhang, Wei and Zhang, Helong and Zhao, Yanqiu and Zhao, Jun and Zhou, Jianying and Zhou, Caicun and Zhou, Xiangdong and Kolek, Vitezslav and Koubkova, Leona and Roubec, Jaromir and Skrickova, Jana and Zemanova, Milada and Chouaid, Christos and Hilgers, Werner and Lena, Hervé and Moro-Sibilot, Denis and Robinet, Gilles and Souquet, Pierre-Jean and Alt, Jürgen and Bischoff, Helge and Grohe, Christian and Laack, Eckart and Lang, Susanne and Panse, Jens and ... and CASPIAN Investigators and CASPIAN investigators
The Lancet, ISSN 0140-6736, 11/2019, Volume 394, Issue 10212, pp. 1929 - 1939
Most patients with small-cell lung cancer (SCLC) have extensive-stage disease at presentation, and prognosis remains poor. Recently, immunotherapy has... 
PROPHYLACTIC CRANIAL IRRADIATION | SCLC | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | CISPLATIN | Antineoplastic Agents, Immunological - administration & dosage | Lung Neoplasms - drug therapy | Etoposide - adverse effects | Drug Administration Schedule | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols | Carboplatin - administration & dosage | Etoposide - administration & dosage | Male | Small Cell Lung Carcinoma - drug therapy | Cisplatin - administration & dosage | Carboplatin - adverse effects | Antineoplastic Agents, Immunological - adverse effects | Antineoplastic Agents, Phytogenic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal - administration & dosage | Progression-Free Survival | Cisplatin - adverse effects | Female | Small Cell Lung Carcinoma - mortality | Aged | Etoposide | Care and treatment | Product development | Lung cancer | Analysis | Drugs | Medical services | Radiation | Clinical trials | Metastasis | Cancer therapies | Randomization | Motivation | Platinum | Immunotherapy | Safety | Neutropenia | Small cell lung carcinoma | Maintenance | Radiation therapy | Survival | Patients | Cisplatin | Response rates | Carboplatin | Irradiation | Ligands | Clinical medicine | Solid tumors | Tumors | Apoptosis
Journal Article
Journal Article
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S1079 - S1080
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. 604 - 604
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 4_suppl, pp. 764 - 764
764 Background: Inhibiting the transforming growth factor β (TGF-β) pathway, which plays a key role in tumor immunosuppression, may enhance the response to... 
Journal Article
Journal Article
ISSN 1473-0197, 5/2019, Volume 19, Issue 1, pp. 186 - 1876
Isolation of circulating tumor cells (CTCs) from blood provides a minimally-invasive alternative for basic understanding, diagnosis, and prognosis of... 
Journal Article